Literature DB >> 11072438

Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal.

S S Watkins1, G F Koob, A Markou.   

Abstract

The neurobiology of nicotine addiction is reviewed within the context of neurobiological and behavioral theories postulated for other drugs of abuse. The roles of various neurotransmitter systems, including acetylcholine, dopamine, serotonin, glutamate, gamma-aminobutyric acid, and opioid peptides in acute nicotine reinforcement and withdrawal from chronic administration are examined followed by a discussion of potential neuroadaptations within these neurochemical systems that may lead to the development of nicotine dependence. The link between nicotine administration, depression and schizophrenia are also discussed. Finally, a theoretical model of the neurobiological mechanisms underlying acute nicotine withdrawal and protracted abstinence involves alterations within dopaminergic, serotonergic, and stress systems that are hypothesized to contribute to the negative affective state associated with nicotine abstinence.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11072438     DOI: 10.1080/14622200050011277

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  154 in total

1.  Effects of repeated withdrawal episodes, nicotine dose, and duration of nicotine exposure on the severity and duration of nicotine withdrawal in rats.

Authors:  Karen L Skjei; Athina Markou
Journal:  Psychopharmacology (Berl)       Date:  2003-04-24       Impact factor: 4.530

Review 2.  Anxiety, depression, and cigarette smoking: a transdiagnostic vulnerability framework to understanding emotion-smoking comorbidity.

Authors:  Adam M Leventhal; Michael J Zvolensky
Journal:  Psychol Bull       Date:  2014-11-03       Impact factor: 17.737

3.  Correlation and predictive performances of saliva and plasma nicotine concentration on tobacco withdrawal-induced craving.

Authors:  Vincenzo Teneggi; Lisa Squassante; Laura Iavarone; Stefano Milleri; Alan Bye; Roberto Gomeni
Journal:  Br J Clin Pharmacol       Date:  2002-10       Impact factor: 4.335

Review 4.  Why people smoke.

Authors:  Martin J Jarvis
Journal:  BMJ       Date:  2004-01-31

5.  Precipitated withdrawal from nicotine reduces reinforcing effects of a visual stimulus for rats.

Authors:  Matthew T Weaver; Maggie Sweitzer; Sarah Coddington; Jaimee Sheppard; Nicole Verdecchia; Anthony R Caggiula; Alan F Sved; Eric C Donny
Journal:  Nicotine Tob Res       Date:  2012-01-04       Impact factor: 4.244

6.  Shifting pharmacology of nicotine use and withdrawal: breaking the cycle of drug abuse.

Authors:  Thibaut Sesia; Anthony A Grace
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-03       Impact factor: 11.205

7.  The role of nicotinic acetylcholine receptors in the medial prefrontal cortex and hippocampus in trace fear conditioning.

Authors:  J D Raybuck; T J Gould
Journal:  Neurobiol Learn Mem       Date:  2010-08-19       Impact factor: 2.877

8.  Genetic ancestry as an effect modifier of naltrexone in smoking cessation among African Americans: an analysis of a randomized controlled trial.

Authors:  Adam Bress; Rick Kittles; Coady Wing; Stanley E Hooker; Andrea King
Journal:  Pharmacogenet Genomics       Date:  2015-06       Impact factor: 2.089

Review 9.  Waterpipe tobacco smoking: an emerging health crisis in the United States.

Authors:  Caroline Cobb; Kenneth D Ward; Wasim Maziak; Alan L Shihadeh; Thomas Eissenberg
Journal:  Am J Health Behav       Date:  2010 May-Jun

10.  Nicotine withdrawal produces a decrease in extracellular levels of dopamine in the nucleus accumbens that is lower in adolescent versus adult male rats.

Authors:  Luis A Natividad; Hugo A Tejeda; Oscar V Torres; Laura E O'Dell
Journal:  Synapse       Date:  2010-02       Impact factor: 2.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.